Open access
Open access
Powered by Google Translator Translator

Archives

RCT: Lopinavir-ritonavir and hydroxychloroquine worsened outcomes in critically ill patients with COVID-19.

14 Jul, 2021 | 11:25h | UTC

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial – Intensive Care Medicine

 

Commentary on Twitter (thread – click for more)

 


Acute promyelocytic leukemia current treatment algorithms.

15 Jul, 2021 | 09:01h | UTC

Acute promyelocytic leukemia current treatment algorithms – Blood Cancer Journal

 


Opinion | The case for mandating COVID-19 vaccines for health care workers.

14 Jul, 2021 | 11:22h | UTC

The Case for Mandating COVID-19 Vaccines for Health Care Workers – Annals of Internal Medicine

News release: Case is strong for mandating COVID-19 vaccination for health care workers – American College of Physicians

 

Commentary on Twitter

 


RCT: Neither Remdesivir nor Hydroxychloroquine affect viral clearance in hospitalized patients with COVID-19.

14 Jul, 2021 | 11:23h | UTC

News release: Neither remdesivir nor HCQ affect viral clearance in hospitalized patients with COVID-19 – American College of Physicians

Original Study: Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 – Annals of Internal Medicine

 

Commentary on Twitter

 


[Preprint] Wastewater genomic testing can effectively track COVID-19 variants of concern.

14 Jul, 2021 | 11:19h | UTC

UBC research shows wastewater genomic testing can effectively track COVID-19 variants of concern within a region – University of British Columbia

Original Study: Assessing multiplex tiling PCR sequencing approaches for detecting genomic variants of SARS-CoV-2 in municipal wastewater – medRxiv

Related: Perspective | Sewage sleuths helped an Arizona town beat back Covid-19. For wastewater epidemiology, that’s just the start. (texts on the subject) AND Human Waste Could Be The Next Big Weapon in Controlling COVID-19 – TIME

 

Commentary on Twitter (thread – click for more)

 


Cohort study: Pfizer/BioNTech COVID vaccine associated with 78% lower risk of Covid-19 in pregnancy.

14 Jul, 2021 | 11:20h | UTC

Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women – JAMA

Commentary: Pfizer COVID vaccine shows 78% efficacy in pregnancy – CIDRAP

 


Real-World Evidence: The low validity of temperature screening for COVID-19 triage.

14 Jul, 2021 | 11:11h | UTC

Real-World Evidence: The Low Validity of Temperature Screening for COVID-19 Triage – Frontiers in Public Health

 

Commentary on Twitter

 


New Zealand children falling ill in high numbers due to Covid ‘immunity debt’.

14 Jul, 2021 | 11:16h | UTC

New Zealand children falling ill in high numbers due to Covid ‘immunity debt’ – The Guardian

Related: New Zealand, where Covid-19 is dormant, fights another respiratory virus – The New York Times


Next steps for wastewater testing to help end this pandemic — and prevent the next one.

14 Jul, 2021 | 11:18h | UTC

Next steps for wastewater testing to help end this pandemic — and prevent the next one – STAT

Author interview: A biostatistician on the ‘gold mine’ in our sewers – STAT

Related: Perspective | Sewage sleuths helped an Arizona town beat back Covid-19. For wastewater epidemiology, that’s just the start. (texts on the subject) AND Human Waste Could Be The Next Big Weapon in Controlling COVID-19 – TIME

 


One COVID vaccine dose yields good protection in elderly, 2 studies find.

14 Jul, 2021 | 11:15h | UTC

One COVID vaccine dose yields good protection in elderly, 2 studies find – CIDRAP

Original study 1: Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study – The Lancet Infectious Diseases

Original Study 2: Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study – The Lancet Infectious Diseases

 

Commentary on Twitter (thread – click for more)

 


AAP Technical Report | Prevention of Drowning.

14 Jul, 2021 | 11:09h | UTC

Prevention of Drowning – Pediatrics

News releases: American Academy of Pediatrics Identifies Children Most at Risk of Drowning and Recommends Layers of Protection to Prevent Tragedy – American Academy of Pediatrics AND New information, research adds to understanding of drowning risks, precautions – AAP News

Related: The Burden of Unintentional Drowning: Global, Regional and National Estimates of Mortality from the Global Burden of Disease Study AND Preventing drowning: an implementation guide – World Health Organization AND Global report on drowning: preventing a leading killer – World Health Organization AND Report: Open Water Drowning and Risks for Children AND Wilderness Medical Society Clinical Practice Guidelines for the Treatment and Prevention of Drowning: 2019 Update – Wilderness and Environmental Medicine

 

Commentary on Twitter

 


WHO: New study highlights unacceptably high global prevalence of syphilis among men who have sex with men.

14 Jul, 2021 | 11:04h | UTC

New study highlights unacceptably high global prevalence of syphilis among men who have sex with men – World Health Organization

Original Study: Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000–20 – The Lancet Global Health

Commentary: Syphilis in men who have sex with men: advancing research and human rights – The Lancet Global Health

 


Global burden of cancer attributable to alcohol consumption – “Globally, an estimated 741.300, or 4·1% of all new cases of cancer in 2020 were attributable to alcohol consumption”.

14 Jul, 2021 | 11:07h | UTC

Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study – The Lancet Oncology

News release: Alcohol consumption linked to more than 740,000 new cancer cases in 2020 – The Lancet

Commentaries: Alcohol caused 740,000 cancer cases globally last year – study – The Guardian AND Expert reaction to study of alcohol and cancer – Science Media Centre

 


Review: Diagnosis, evaluation, and treatment of adenomyosis.

14 Jul, 2021 | 11:01h | UTC

Diagnosis, Evaluation, and Treatment of Adenomyosis – JAMA (free for a limited period)

 


Review: Diagnosis and treatment of alcohol-associated liver disease.

14 Jul, 2021 | 11:02h | UTC

Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review – JAMA (free for a limited period)

Audio Clinical Review: Diagnosis and Treatment of Alcohol-Associated Liver Disease – JAMA

 


Summary: SGLT2 inhibitors and GLP-1 receptor agonists established and emerging indications.

14 Jul, 2021 | 10:56h | UTC

SGLT2 Inhibitors and GLP-1 Receptor Agonists: Indications – American College of Cardiology

Original review: SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications – The Lancet (link to abstract – $ for full-text)

Related guideline: SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes – This guidance recommends a risk-based approach, advising against starting SGLT-2 inhibitors or GLP-1 receptor agonists in patients with three or fewer cardiovascular risk factors and without established CVD or CKD.

 


A UK expert consensus approach for managing symptomatic arteriovenous fistula (AVF) stenosis in hemodialysis patients.

14 Jul, 2021 | 10:55h | UTC

A UK Expert Consensus Approach for Managing Symptomatic Arteriovenous Fistula (AVF) Stenosis in Haemodialysis Patients – CardioVascular and Interventional Radiology

 


Summary | Universal definition and classification of heart failure: a step in the right direction from failure to function.

14 Jul, 2021 | 10:58h | UTC

Universal Definition and Classification of Heart Failure: A Step in the Right Direction from Failure to Function – American College of Cardiology

 


FDA Safety Alert: hydroxyethyl starch products should not be used unless adequate alternative treatment is unavailable.

14 Jul, 2021 | 10:48h | UTC

Labeling Changes on mortality, kidney injury, and excess bleeding with hydroxyethyl starch products – U.S. Food and Drug Administration

Commentary: FDA Piles on New Warnings for Blood Volume Expanders – MedPage Today (free registration required)

Related: Hydroxyethyl-starch Solutions (HES) Should no Longer be Used – European Medicines Agency AND Randomized Trial: Hydroxyethyl Starch vs. Saline for Volume Replacement Therapy in High-Risk Patients Undergoing Major Abdominal Surgery AND Systematic Review: Colloids vs Crystalloids for Fluid Resuscitation in Critically Ill People

 


SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.

14 Jul, 2021 | 10:53h | UTC

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe – European Heart Journal

See also: SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions – European Heart Journal

Editorial: Redefining cardiovascular risk prediction: is the crystal ball clearer now?

Commentary: New risk calculator to save many more lives from heart attack and stroke – University of Cambridge

 

Commentary on Twitter (thread – click for more)

 


German national treatment guidance for hospitalized COVID-19 patients.

13 Jul, 2021 | 10:02h | UTC

Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021) – Infection

 


Long Covid: 39% of patients report persistent symptoms more than seven months after diagnosis of COVID-19 in an outpatient setting.

13 Jul, 2021 | 09:57h | UTC

Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting – Annals of Internal Medicine

Commentaries: Long COVID symptoms in a third of people with COVID-19 – American College of Physicians AND Covid-19: 1-in-3 Patients Reported Long-Hauler Symptoms – Physician’s Weekly

 

Commentary on Twitter

 


WHO warns against mixing and matching COVID vaccines.

13 Jul, 2021 | 09:53h | UTC

WHO warns against mixing and matching COVID vaccines – Reuters

Commentary: WHO cautions data still limited on mixing COVID-19 vaccines, but Canadian officials say it’s OK – CTV News

Related: Germany issues world’s strongest recommendation for mixing Covid-19 vaccines. AND [Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system”. AND Perspective | Can I get AstraZeneca now and Pfizer later? Why mixing and matching COVID vaccines could help solve many rollout problems. AND RCT: Mixing 2 different Covid vaccines is associated with increased risk of side effects. AND Should you mix and match COVID-19 vaccines? Scientists are seeking answers

 

Commentary on Twitter

 


Large genomic analysis has identified 13 new genomic regions associated with susceptibility and severity to Covid-19.

13 Jul, 2021 | 09:59h | UTC

Mapping the human genetic architecture of COVID-19 – Nature

Commentaries: The quest to find genes that drive severe COVID – Nature AND Gene hunters turn up new clues to help explain why Covid-19 hits some people so hard – STAT AND Large genomic analysis highlights COVID-19 risk factors – Broad Institute of MIT and Harvard AND A new study finds genetic variations in Covid patients that could point to better drug treatments. – The New York Times AND How your DNA may affect whether you get COVID-19 or become gravely ill – ScienceNews

 


[Preprint] Long Covid: Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people.

13 Jul, 2021 | 09:55h | UTC

Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people – medRxiv

Commentary: Study explores the prevalence of long COVID in England – News Medical

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.